Foscarnet Sodium Hexahydrate

• CAT Number: R051589
• CAS Number: 34156-56-4
• Molecular Formula: CH12Na3O11P
• Molecular Weight: 300.039
• Purity: ≥95%
• Synonyms: 1,1-Dihydroxyphosphinecarboxylic Acid 1-Oxide Sodium Salt Hydrate; A 29622 Hydrate; EHB 776 Hydrate; Foscavir Hydrate; Gefin Hydrate; PFA Hydrate; Phosphonoformic Acid Trisodium Salt Hydrate; Triapten Hexahydrate; Trisodium Phosphonoformate Hexahydra
• Target: DNA/RNA Synthesis
• Storage: Desiccate at +4℃
• IUPAC Name: trisodium;phosphonatoformate;hexahydrate
• InChI: InChI=1S/CH3O5P.3Na.6H2O/c2-1(3)7(4,5)6;;;;;;;;;/h(H,2,3)(H2,4,5,6);;;;6*1H2/q;3*+1;;;;;;/p-3
• InChIKey: ILRVASBWNRYBFD-UHFFFAOYSA-K
• SMILES: C(=O)([O-])P(=O)([O-])[O-].O.O.O.O.O.O.[Na+].[Na+].[Na+]

Foscarnet Sodium Hexahydrate is a phosphonoformic acid derivative used as an antiviral agent, primarily for the treatment of cytomegalovirus (CMV) infections in immunocompromised patients. This compound functions as a pyrophosphate analog, inhibiting viral DNA polymerase and thereby preventing viral replication. The hexahydrate form enhances its solubility in aqueous solutions, making it suitable for intravenous administration. Research into Foscarnet Sodium Hexahydrate highlights its efficacy against various viral pathogens, including herpes simplex virus (HSV) and HIV. Its use is especially critical in patients who are resistant to conventional antiviral therapies, emphasizing its importance in managing viral infections in clinical settings.